Mangalam Drugs & Organics Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹2.23 billion
- Book Value:
- Revenue TTM:
- ₹3.52 billion
- Operating Margin TTM:
- Gross Profit TTM:
- ₹846.61 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Mangalam Drugs & Organics Limited had its IPO on under the ticker symbol 532637.
The company operates in the Healthcare sector and Drugs - Generic industry. Mangalam Drugs & Organics Limited has a staff strength of 387 employees.
Shares of Mangalam Drugs & Organics Limited opened at ₹107.55 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹104.75 - ₹109, and closed at ₹105.1.
This is a -2.23% slip from the previous day's closing price.
A total volume of 16,955 shares were traded at the close of the day’s session.
In the last one week, shares of Mangalam Drugs & Organics Limited have increased by +0.14%.
Mangalam Drugs & Organics Limited's Key Ratios
Mangalam Drugs & Organics Limited has a market cap of ₹2.23 billion, indicating a price to book ratio of 2.403 and a price to sales ratio of 0.7798.
In the last 12-months Mangalam Drugs & Organics Limited’s revenue was ₹3.52 billion with a gross profit of ₹846.61 million and an EBITDA of ₹393.89 million. The EBITDA ratio measures Mangalam Drugs & Organics Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Mangalam Drugs & Organics Limited’s operating margin was 10.36% while its return on assets stood at 9.64% with a return of equity of 23.73%.
In Q3, Mangalam Drugs & Organics Limited’s quarterly earnings growth was a positive 1272.5% while revenue growth was a positive 45.2%.
Mangalam Drugs & Organics Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹16.46 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Mangalam Drugs & Organics Limited’s profitability.
Mangalam Drugs & Organics Limited stock is trading at a EV to sales ratio of 0.8561 and a EV to EBITDA ratio of 10.0899. Its price to sales ratio in the trailing 12-months stood at 0.7798.
Mangalam Drugs & Organics Limited stock pays annual dividends of ₹0.5 per share, indicating a yield of 0.29% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹3.60 billion
- Total Liabilities
- ₹1.65 billion
- Operating Cash Flow
- Capital Expenditure
- ₹279.14 million
- Dividend Payout Ratio
Mangalam Drugs & Organics Limited ended 2023 with ₹3.60 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹3.60 billion while shareholder equity stood at ₹1.52 billion.
Mangalam Drugs & Organics Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹1.65 billion in other current liabilities, 158282000.00 in common stock, ₹1.36 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹76000.00 and cash and short-term investments were ₹99.87 million. The company’s total short-term debt was ₹495,671,000 while long-term debt stood at ₹187.66 million.
Mangalam Drugs & Organics Limited’s total current assets stands at ₹2.07 billion while long-term investments were ₹0 and short-term investments were ₹72.99 million. Its net receivables were ₹465.33 million compared to accounts payable of ₹0 and inventory worth ₹1.37 billion.
In 2023, Mangalam Drugs & Organics Limited's operating cash flow was ₹-221723000.00 while its capital expenditure stood at ₹279.14 million.
Comparatively, Mangalam Drugs & Organics Limited paid ₹0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Mangalam Drugs & Organics Limited stock is currently trading at ₹105.1 per share. It touched a 52-week high of ₹172.65 and a 52-week low of ₹172.65. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹106.86 and 200-day moving average was ₹114.62 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5053% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Mangalam Drugs & Organics Limited
Similar Industry Stocks (Drugs - Generic)
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. Mangalam Drugs & Organics Limited was incorporated in 1972 and is based in Mumbai, India.